NPS Stimulants (Bath Salts Panel), Urine
Also known as: BATH SALTS
Use
This test is utilized to assess exposure to novel psychoactive stimulants commonly referred to as 'bath salts'. These substances can induce stimulating effects similar to those of drugs like MDMA and cocaine. The test is beneficial for detecting these substances in urine up to several days post-exposure, which is useful in both clinical toxicology settings and forensic investigations where confirmation of ingestion is required.
Special Instructions
For the assessment of acute exposure, the Bath Salts Qualitative Panel in Serum or Plasma (Test Code: 2011411) may be more appropriate. Specimens must be sent separately if multiple tests are ordered concurrently, as this test is not performed in-house at ARUP Laboratories.
Limitations
While this test identifies the presence of specific synthetic stimulants in urine, it does not provide information on the quantity ingested or the potential pharmacological impact on the individual. The detection window and sensitivity can vary based on numerous factors including the specific metabolite and individual metabolic rates. Furthermore, false negatives may occur if the analysis occurs outside of the stability period.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 72795-8
Result Turnaround Time
8-11 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
1 mL
Minimum Volume
0.4 mL
Container
ARUP standard transport tube
Collection Instructions
Transport 1 mL urine in an ARUP standard transport tube. Ensure separate specimens are submitted when multiple tests are ordered.
Storage Instructions
Frozen transport is preferred, refrigeration is also acceptable.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 1 week |
| Refrigerated | 2 weeks |
| Frozen | 2 weeks |